RecruitingCOPD (Chronic Obstructive Pulmonary Disease)
COPD Exacerbation Follow Up
Eligible age
40+ yrs
Accepts
All genders
Locations
4 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.
Sponsor: Viz.ai, Inc.
You may qualify if…
- ✓ Patients aged 40 years or older at the time of arrival to the emergency department.
- ✓ Patients with a clinical diagnosis of COPD who present to the emergency department for a moderate or severe COPD exacerbation.
- ✓ A moderate exacerbation is defined as an acute exacerbation requiring either systemic corticosteroids (such as intramuscular, intravenous or oral) and/or antibiotics.
- ✓ A severe exacerbation is defined as an acute exacerbation requiring hospitalization, or observation for \>24 hours in emergency department/urgent care facility or resulting in death.
- ✓ Patients on dual (LABA/LAMA, LABA/ICS, LAMA/ICS) or triple (LABA/LAMA/ICS) long-acting bronchodilator inhalers.
You may not qualify if…
- ✕ Patients on bronchodilator inhaler monotherapy.
- ✕ Patients leaving against medical advice or expiring during hospitalization.
- ✕ Patients with tracheostomy.
- ✕ Patients with advanced cancer.
- ✕ Patients who have received a lung transplant.
- ✕ Discharge to hospice care.
- ✕ Transfer to another hospital.
Where it's recruiting
Source: ClinicalTrials.gov · NCT07118306 · last updated 2026-06-03